In CLL and DLBCL, investigators have observed altered CD4+ to CD8+ T cell ratio, inverted T helper (Th)1 to Th2 ratio and increased exhausted T cells expressing TIM-3, LAG-3 and PD-1 (23, 24). The gene discussed is LAG3; the disease is diffuse large B-cell lymphoma.